Call Options

10 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.57 - $0.8 $1,140 - $1,600
2,000 New
2,000 $1,000
Q4 2020

Feb 10, 2021

SELL
$4.04 - $5.31 $12,079 - $15,876
-2,990 Reduced 99.67%
10 $0
Q3 2020

Nov 13, 2020

SELL
$3.64 - $7.76 $10,920 - $23,280
-3,000 Reduced 50.0%
3,000 $0
Q2 2020

Aug 10, 2020

SELL
$4.78 - $8.26 $15,296 - $26,432
-3,200 Reduced 34.78%
6,000 $2,000
Q1 2020

May 21, 2020

BUY
$4.0 - $21.53 $36,800 - $198,076
9,200 New
9,200 $10,000
Q4 2019

Feb 14, 2020

SELL
$13.94 - $24.12 $27,880 - $48,240
-2,000 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$13.89 - $23.16 $13,890 - $23,160
-1,000 Reduced 33.33%
2,000 $1,000
Q2 2019

Aug 13, 2019

SELL
$16.27 - $20.51 $4,881 - $6,153
-300 Reduced 9.09%
3,000 $13,000
Q1 2019

May 15, 2019

BUY
$12.61 - $22.33 $22,698 - $40,194
1,800 Added 120.0%
3,300 $13,000
Q3 2018

Nov 09, 2018

BUY
$2.45 - $16.27 $3,675 - $24,405
1,500 New
1,500 $17,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $177M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.